Exp Mol Med.
1998 Dec;30(4):263-269.
The regulatory mechanism of phosphatidylinositol 3-kinase by insulin in 3T3 L1 fibroblasts: phosphorylation-independent activation of phosphatidylinositol 3-kinase
- Affiliations
-
- 1Department of Molecular Biology, School of Medicine, Kyung Hee University, Seoul, Korea.
Abstract
- Phosphatidylinositol (PI) 3-kinase plays an important role in transducing the
signals of various growth factor receptors. However, the regulatory mechanism of
PI3-kinase activity by these growth factor receptors is not completely
understood. Therefore, we attempted to clarify the regulatory mechanism of
PI3-kinase using insulin and 3T3 L1 fibroblasts. Our results showed that insulin
stimulated PI3-kinase activity seven-fold and concomitantly phosphorylated a p85
subunit at the tyrosine residue. However, this tyrosine phosphorylation was not
significant in the activation of PI3-kinase as the PI3-kinase pulled down by the
overexpressed GST-p85 fusion protein showed as high an activity as the
immunoprecipitated one. The p110 subunit was phosphorylated at both serine and
tyrosine residues without insulin treatment. Since the phosphorylation state was
not changed by insulin. The results suggested that phosphorylation of the p110
subunit does not control PI3-kinase activity. Finally, it was shown that the
insulin receptor substrate-1 (IRS-1) binding to PI3-kinase was not sufficient
for full activation because the amount of IRS-1 pulled down by the GST-p85
fusion protein reached almost maximum, after incubation with insulin-treated
cell lysates for 20 min, whereas PI3-kinase activity reached its maximum only
after incubation for 5 h. All results suggest that the phosphorylation of p85
subunit at tyrosine residues and phosphorylation of p110 subunit at tyrosine or
serine residues are not functionally significant in the regulation of PI3-kinase
activity. They also suggest that P13-kinase is needed to bind to other
protein(s) as well as the insulin receptor substrate-1 for full activation.